Ratings DuPont de Nemours, Inc. London S.E.

Equities

0A6B

US26614N1028

Delayed London S.E. 10:15:34 2024-06-07 am EDT 5-day change 1st Jan Change
79.63 USD +0.00% Intraday chart for DuPont de Nemours, Inc. -0.18% +3.75%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Sales forecast by analysts have been recently revised upwards.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • The firm trades with high earnings multiples: 30.53 times its 2024 earnings per share.
  • The company's enterprise value to sales, at 3.17 times its current sales, is high.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
+3.75% 33.48B -
+3.85% 79B
B
-6.85% 43.83B
A-
+14.14% 18.74B
B
+14.20% 12.06B
A-
-4.23% 10.43B -
-22.09% 10.17B
B
-2.89% 8.87B
A-
-3.33% 8.51B
C-
-13.07% 5.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DD Stock
  4. 0A6B Stock
  5. Ratings DuPont de Nemours, Inc.